Based on previous cardio-oncology experience in lung and prostate cancer, we can confirm the prognostic and predictive value of classic cardiac biomarkers (D-dimer, NT-proBNP, troponin), modern biomarkers, and echocardiography parameters such as GLS of the left and right ventricle [18–21]. The gene discussed is NPPB; the disease is prostate carcinoma.